Spots Global Cancer Trial Database for targeted axillary dissection (tad) by blue patent
Every month we try and update this database with for targeted axillary dissection (tad) by blue patent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| ICG vs Blue Patent as a Tracer in the Performance of TAD in Patients With cN1 Breast Carcinoma After Neoadjuvant Chemotherapy | NCT06339658 | Breast Cancer Axillary Metast... | Targeted axilla... Targeted axilla... | 18 Years - | Hospital Universitari de Bellvitge | |
| ICG vs Blue Patent as a Tracer in the Performance of TAD in Patients With cN1 Breast Carcinoma After Neoadjuvant Chemotherapy | NCT06339658 | Breast Cancer Axillary Metast... | Targeted axilla... Targeted axilla... | 18 Years - | Hospital Universitari de Bellvitge |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
